Pancreatic Cancer Research

ResearcherSeoul National UniversityActive in the last 2 years

Jai Young Cho

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1376-956X; OpenAlex author ID A5070292254. Sources: OpenAlex.

Their work

Papers
14 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
27
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: 4 papers · 2016: 1 paper · 2017: 2 papers · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 14

  1. Development of an Immunodeficient Pig Model for Pancreatic Cancer Xenotransplantation Using Splenectomy, Thymectomy, and Oral Immunosuppression. Co-author DOI 10.3390/medicina61040586↗
  2. Validation of the Anatomical and Biological Definitions of Borderline Resectable Pancreatic Cancer According to the 2017 International Consensus for Survival a… Co-author DOI 10.1245/s10434-022-13043-5↗
  3. Impact of Acute Inflammation on the Survival Outcomes of Patients with Resected Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1159/000520063↗
  4. Prognosis prediction of pancreatic cancer after curative intent surgery using imaging parameters derived from F-18 fluorodeoxyglucose positron emission tomogra… Co-author DOI 10.1097/md.0000000000021829↗
  5. Human equilibrative nucleoside transporter-1 (hENT1) and ribonucleotide reductase regulatory subunit M1 (RRM1) expression; do they have survival impact to panc… Co-author DOI 10.14701/ahbps.2020.24.2.127↗
  6. Laparoscopic subtotal pancreatectomy with radical antegrade modular pancreatosplenectomy for left-sided pancreatic cancer. Last author DOI 10.1016/j.suronc.2018.12.006↗
  7. Prognostic Relevance of the Timing of Initiating and the Completion of Adjuvant Therapy in Patients with Resected Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1007/s00268-016-3798-1↗
  8. Prognostic value of p21-activated kinase 4 in resected pancreatic cancer. Co-author DOI 10.1111/apm.12705↗
  9. Prognostic relevance of preoperative diabetes mellitus and the degree of hyperglycemia on the outcomes of resected pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/jso.24133↗
  10. Lower maximum standardized uptake value of fluorine-18 fluorodeoxyglucose positron emission tomography coupled with computed tomography imaging in pancreatic d… Co-author DOI 10.1016/j.amjsurg.2014.06.038↗
  11. Postoperative early thromboembolism as a prognostic indicator in patients with curatively resected pancreatic cancer. Co-author DOI 10.1016/j.amjsurg.2014.12.051↗
  12. Presence of pancreatic intraepithelial neoplasia-3 in a background of chronic pancreatitis in pancreatic cancer patients. Co-author DOI 10.1111/cas.12744↗
  13. Postoperative carcinoembryonic antigen as a complementary tumor marker of carbohydrate antigen 19-9 in pancreatic ductal adenocarcinoma. Co-author DOI 10.3346/jkms.2015.30.3.259↗
  14. Breast cancer resistance protein expression is associated with early recurrence and decreased survival in resectable pancreatic cancer patients. Co-author DOI 10.1111/j.1440-1827.2011.02772.x↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yoo‐Seok Yoon · 14 shared papers, 2012–2025 · strength 1.46
  2. Ho‐Seong Han · 14 shared papers, 2012–2025 · strength 1.46
  3. Jun Suh Lee · 3 shared papers, 2021–2025 · strength 0.60
  4. Yeshong Park · 2 shared papers, 2023–2025 · strength 0.45
  5. MeeYoung Kang · 2 shared papers, 2023–2025 · strength 0.45
  6. Boram Lee · 2 shared papers, 2023–2025 · strength 0.45
  7. Jin‐Hyeok Hwang · 6 shared papers, 2012–2017 · strength 0.31
  8. Dae Wook Hwang · 2 shared papers, 2015–2020 · strength 0.20
  9. In Kyeom Hwang · 3 shared papers, 2015 · strength 0.16
  10. Yoon Suk Lee · 3 shared papers, 2015 · strength 0.16
  11. Jaihwan Kim · 3 shared papers, 2015 · strength 0.16
  12. Mohamed Rabie Saad · 1 shared paper, 2021 · strength 0.16
  13. Ahmed Shehta · 1 shared paper, 2021 · strength 0.16
  14. Haeryoung Kim · 3 shared papers, 2012–2017 · strength 0.15
  15. Seongho Kim · 1 shared paper, 2019 · strength 0.14
  16. Woohyung Lee · 2 shared papers, 2016–2017 · strength 0.14
  17. Won‐Woo Lee · 1 shared paper, 2020 · strength 0.13
  18. Min Young Yoo · 1 shared paper, 2020 · strength 0.13
  19. Sang Hyub Lee · 2 shared papers, 2012–2015 · strength 0.09
  20. Woohyun Jung · 1 shared paper, 2017 · strength 0.07
  21. Sun‐Whe Kim · 1 shared paper, 2017 · strength 0.07
  22. Wooil Kwon · 1 shared paper, 2017 · strength 0.07
  23. Hanlim Choi · 1 shared paper, 2016 · strength 0.07
  24. Sehhoon Park · 1 shared paper, 2017 · strength 0.06
  25. Jin Won Kim · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.